{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T19:12:19Z","timestamp":1786389139988,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2025R381"],"award-info":[{"award-number":["PNURSP2025R381"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tice.2025.103092","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:48:16Z","timestamp":1755496096000},"page":"103092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Attenuation of NF-\u03baB\/NLRP3 inflammasome axis and oxidative stress, and upregulation of Nrf2\/HO-1 signaling mediate the protective effect of S-carboxymethylcysteine against cyclophosphamide-induced cardiotoxicity"],"prefix":"10.1016","volume":"97","author":[{"given":"Reem S.","family":"Alruhaimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad H.M.","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman M.","family":"Alnasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad F.","family":"Ahmeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan S.","family":"Althagafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr M.T.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamada S.","family":"Qebesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0279-6500","authenticated-orcid":false,"given":"Ayman M.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tice.2025.103092_bib1","first-page":"838","article-title":"Heme metabolism and erythropoiesis in abnormal iron states: role of \u03b4-aminolevulinic acid synthase and heme oxygenase","volume":"13","author":"Abraham","year":"1985","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tice.2025.103092_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116019","article-title":"Acetate attenuates cyclophosphamide-induced cardiac injury via inhibition of NF-kB signaling and suppression of caspase 3-dependent apoptosis in wistar rats","volume":"170","author":"Adeyemi","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"8","key":"10.1016\/j.tice.2025.103092_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/biom9080346","article-title":"Galangin activates Nrf2 signaling and attenuates oxidative damage, inflammation, and apoptosis in a rat model of Cyclophosphamide-Induced hepatotoxicity","volume":"9","author":"Aladaileh","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.tice.2025.103092_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152242","article-title":"Modulation of NF-\u03baB\/NLRP3 inflammasome axis, Nrf2\/HO-1 signaling and attenuation of oxidative stress mediate the protective effect of ambroxol against cyclophosphamide cardiotoxicity","volume":"776","author":"Alruhaimi","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.tice.2025.103092_bib5","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.4049\/jimmunol.172.4.2522","article-title":"Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B","volume":"172","author":"Asehnoune","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.tice.2025.103092_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.vh.2022.09.002","article-title":"The antioxidant glutathione","volume":"121","author":"Averill-Bates","year":"2023","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.tice.2025.103092_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0065-2776(08)60742-7","article-title":"NF-kappa b as a frequent target for immunosuppressive and anti-inflammatory molecules","volume":"65","author":"Baeuerle","year":"1997","journal-title":"Adv. Immunol."},{"issue":"7","key":"10.1016\/j.tice.2025.103092_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134694","article-title":"Mitochondrial apoptotic pathway is activated by H2O2-mediated oxidative stress in BmN-SWU1 cells from bombyx mori ovary","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tice.2025.103092_bib9","article-title":"Cyclophosphamide-Induced cardiomyopathy: a case report, review, and recommendations for management","volume":"1","author":"Dhesi","year":"2013","journal-title":"J. Invest. Med High. Impact Case Rep."},{"key":"10.1016\/j.tice.2025.103092_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu Rev. Immunol."},{"issue":"19","key":"10.1016\/j.tice.2025.103092_bib11","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1073\/pnas.0611496104","article-title":"Cryopyrin\/NALP3 binds ATP\/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling","volume":"104","author":"Duncan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tice.2025.103092_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cbi.2015.11.009","article-title":"Antihepatotoxic efficacy of mangifera indica L. Polysaccharides against cyclophosphamide in rats","volume":"244","author":"Fahmy","year":"2016","journal-title":"Chem. Biol. Inter."},{"issue":"5","key":"10.1016\/j.tice.2025.103092_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00003495-199142050-00005","article-title":"Cyclophosphamide toxicity","volume":"42","author":"Fraiser","year":"1991","journal-title":"Drugs"},{"issue":"5-6","key":"10.1016\/j.tice.2025.103092_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000185494","article-title":"S-CMC-Lys protective effects on human respiratory cells during oxidative stress","volume":"22","author":"Garavaglia","year":"2008","journal-title":"Cell Physiol. Biochem"},{"issue":"13","key":"10.1016\/j.tice.2025.103092_bib15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2010.03.083","article-title":"Iron overload cardiomyopathy: better understanding of an increasing disorder","volume":"56","author":"Gujja","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.tice.2025.103092_bib16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1378\/chest.10-0920","article-title":"Carbocisteine protects against emphysema induced by cigarette smoke extract in rats","volume":"139","author":"Hanaoka","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.tice.2025.103092_bib17","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.2147\/DDDT.S281854","article-title":"Edaravone and acetovanillone upregulate Nrf2 and PI3K\/Akt\/mTOR signaling and prevent cyclophosphamide cardiotoxicity in rats","volume":"14","author":"Hassanein","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.tice.2025.103092_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci."},{"issue":"13","key":"10.1016\/j.tice.2025.103092_bib19","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tice.2025.103092_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/bja\/aeh148","article-title":"Biochemical markers of myocardial injury","volume":"93","author":"Kemp","year":"2004","journal-title":"Br. J. Anaesth."},{"issue":"5","key":"10.1016\/j.tice.2025.103092_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","article-title":"Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation","volume":"23","author":"Korkmaz","year":"2007","journal-title":"Cell Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.tice.2025.103092_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/mol.65.1.181","article-title":"Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents","volume":"65","author":"Kwok","year":"2004","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.tice.2025.103092_bib23","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"8","key":"10.1016\/j.tice.2025.103092_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0009-9120(99)00075-2","article-title":"Antioxidant enzymes and human diseases","volume":"32","author":"Mat\u00e9s","year":"1999","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.tice.2025.103092_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trsl.2022.08.004","article-title":"NLRP3-mediated inflammation in cardio-oncology: sterile yet harmful","volume":"252","author":"Mauro","year":"2023","journal-title":"Transl. Res"},{"issue":"5","key":"10.1016\/j.tice.2025.103092_bib26","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","article-title":"Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation","volume":"101","author":"McDonald","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.tice.2025.103092_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/03602532.2011.631015","article-title":"S-carboxymethyl-L-cysteine","volume":"44","author":"Mitchell","year":"2012","journal-title":"Drug Metab. Rev."},{"issue":"2","key":"10.1016\/j.tice.2025.103092_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/toxsci\/kfu233","article-title":"Molecular mechanisms of acrolein toxicity: relevance to human disease","volume":"143","author":"Moghe","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.tice.2025.103092_bib29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/leu.2013.359","article-title":"Cyclophosphamide as a first-line therapy in LGL leukemia","volume":"28","author":"Moignet","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.tice.2025.103092_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.847012","article-title":"Cardiotoxicity of anticancer drugs: molecular mechanisms and strategies for cardioprotection","volume":"9","author":"Morelli","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.tice.2025.103092_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/2156587218757649","article-title":"Protective effect of kolaviron on cyclophosphamide-induced cardiac toxicity in rats","volume":"23","author":"Omole","year":"2018","journal-title":"J. Evid. Based Integr. Med"},{"key":"10.1016\/j.tice.2025.103092_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12916-016-0553-2","article-title":"Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature","volume":"14","author":"Onakpoya","year":"2016","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.tice.2025.103092_bib33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/pharmaceutics14061261","article-title":"Clinical efficacy of carbocysteine in COPD: beyond the mucolytic action","volume":"14","author":"Pace","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.tice.2025.103092_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4110\/in.2009.9.1.12","article-title":"Heme oxygenase-1: its therapeutic roles in inflammatory diseases","volume":"9","author":"Pae","year":"2009","journal-title":"Immune Netw."},{"issue":"8","key":"10.1016\/j.tice.2025.103092_bib35","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/annonc\/mdx158","article-title":"Drug-induced liver injury in oncology","volume":"28","author":"Ricart","year":"2017","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.tice.2025.103092_bib36","article-title":"Cyclophosphamide-induced multiple organ dysfunctions: unravelling of dose dependent toxic impact on biochemistry and histology","volume":"13","author":"Sahu","year":"2024","journal-title":"Toxicol. Res (Camb. )"},{"key":"10.1016\/j.tice.2025.103092_bib37","doi-asserted-by":"crossref","first-page":"9237263","DOI":"10.1155\/2017\/9237263","article-title":"The role of Nrf2 in cardiovascular function and disease","volume":"2017","author":"Satta","year":"2017","journal-title":"Oxid. Med Cell Longev."},{"issue":"4","key":"10.1016\/j.tice.2025.103092_bib38","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1021\/acs.jcim.3c01834","article-title":"Insights into drug cardiotoxicity from biological and chemical data: the first public classifiers for FDA Drug-Induced cardiotoxicity rank","volume":"64","author":"Seal","year":"2024","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.tice.2025.103092_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13023-022-02396-5","article-title":"Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study","volume":"17","author":"Sestito","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.tice.2025.103092_bib40","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/0960327120909880","article-title":"Cyclophosphamide induces a significant increase in iron content in the liver and spleen of mice","volume":"39","author":"Sheng","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"issue":"1-2","key":"10.1016\/j.tice.2025.103092_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cbi.2011.02.021","article-title":"Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease","volume":"192","author":"Smathers","year":"2011","journal-title":"Chem. Biol. Inter."},{"issue":"50","key":"10.1016\/j.tice.2025.103092_bib42","doi-asserted-by":"crossref","first-page":"41732","DOI":"10.1074\/jbc.M112.381228","article-title":"Multiple binding sites on the pyrin domain of ASC protein allow self-association and interaction with NLRP3 protein","volume":"287","author":"Vajjhala","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.tice.2025.103092_bib43","doi-asserted-by":"crossref","first-page":"H1453","DOI":"10.1152\/ajpheart.00554.2015","article-title":"Drug-induced mitochondrial dysfunction and cardiotoxicity","volume":"309","author":"Varga","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.tice.2025.103092_bib44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2141.1997.282672.x","article-title":"Cyclophosphamide therapy for pure red cell aplasia associated with granular lymphocyte-proliferative disorders","volume":"97","author":"Yamada","year":"1997","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.tice.2025.103092_bib45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1440-1843.2009.01594.x","article-title":"Carbocisteine inhibits oxidant-induced apoptosis in cultured human airway epithelial cells","volume":"14","author":"Yoshida","year":"2009","journal-title":"Respirology"},{"issue":"3-4","key":"10.1016\/j.tice.2025.103092_bib46","first-page":"215","article-title":"Carbocisteine reduces the cytotoxicity of oxaliplatin","volume":"67","author":"Zhai","year":"2012","journal-title":"Z. Nat. C. J. Biosci."},{"key":"10.1016\/j.tice.2025.103092_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.927061","article-title":"NLRP3 inflammasome: the rising star in cardiovascular diseases","volume":"9","author":"Zheng","year":"2022","journal-title":"Front Cardiovasc Med"}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004081662500374X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004081662500374X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:21:40Z","timestamp":1779891700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004081662500374X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S004081662500374X"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2025.103092","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuation of NF-\u03baB\/NLRP3 inflammasome axis and oxidative stress, and upregulation of Nrf2\/HO-1 signaling mediate the protective effect of S-carboxymethylcysteine against cyclophosphamide-induced cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2025.103092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103092"}}